Short Summary
Apple has filed an IPR petition challenging all 72 claims of CardWare’s ’634 patent covering NFC‑based mobile payment tokenization. The petition argues the claims are obvious over multiple prior‑art references.
Detailed Summary
In a petition for inter partes review (IPR2025‑01152), Apple Inc. seeks to invalidate the 72 claims of CardWare Inc.’s U.S. Patent No. 11,620,634, which describes a method and system for generating limited‑use payment information and conducting NFC‑based transactions on a mobile device. Apple asserts that each claim group is obvious in view of prior‑art references such as Collinge, Lin, Sahota, Smith, Kranzley, Fadell and Yu, and relies on pre‑AIA 35 U.S.C. § 103 unpatentability. The petition includes detailed claim constructions proposed by the patent owner and cites case law supporting the obviousness analysis. Related district‑court litigation between the parties is noted, but no institution decision has yet been made.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Apple Inc. vs CardWare Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Apple Inc.vsApex Beam Technologies LLC
Apple has filed an IPR petition challenging all 20 claims of Apex Beam’s 5G multi‑antenna patent, arguing they are anticipated or obvious over four prior‑art references. The petition seeks institution and cancellation of the claims.
Samsung Electronics America, Inc. et al.vsTelcom Ventures LLC
The USPTO denied Samsung’s request for rehearing of a director’s discretionary denial in IPR2025‑00974 and related cases, leaving Telcom Ventures’ patents untouched.
CrowdStrike, Inc.vsSkysong Innovations, LLC
CrowdStrike has filed an IPR petition challenging all 20 claims of Skysong Innovations’ ’897 patent, asserting that the claims are obvious over multiple prior‑art references covering machine‑learning‑based exploit prediction.
MIM Software Inc. et al.vsProgenics Pharmaceuticals, Inc. et al.
MIM Software has filed a petition to invalidate Progenics' U.S. Patent 11,894,141, asserting that its claims on prostate‑cancer imaging are obvious over prior‑art references such as Maier, Huang and Armor. The petition seeks institution of the IPR and argues against discretionary denial.
Regions BankvsUnited Services Automobile Association
Regions Bank and USAA jointly moved to keep their IPR settlement agreement confidential under 35 U.S.C. § 317(b) and related regulations.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.